These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 23380218

  • 1. Effect of montelukast for treatment of asthma in cigarette smokers.
    Price D, Popov TA, Bjermer L, Lu S, Petrovic R, Vandormael K, Mehta A, Strus JD, Polos PG, Philip G.
    J Allergy Clin Immunol; 2013 Mar; 131(3):763-71. PubMed ID: 23380218
    [Abstract] [Full Text] [Related]

  • 2. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.
    BMJ; 2003 Oct 18; 327(7420):891. PubMed ID: 14563743
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 18; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 4. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P.
    Pediatrics; 2005 Aug 18; 116(2):360-9. PubMed ID: 16061590
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
    Meltzer EO, Lockey RF, Friedman BF, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Propionate Clinical Research Study Group.
    Mayo Clin Proc; 2002 May 18; 77(5):437-45. PubMed ID: 12004993
    [Abstract] [Full Text] [Related]

  • 6. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L, Pizzichini E, Lemière C, Man SF, Cartier A, Hargreave FE, Pizzichini MM.
    Thorax; 2005 Feb 18; 60(2):100-5. PubMed ID: 15681495
    [Abstract] [Full Text] [Related]

  • 7. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, MIAMI Study Research Group.
    J Allergy Clin Immunol; 2007 Apr 18; 119(4):916-23. PubMed ID: 17349681
    [Abstract] [Full Text] [Related]

  • 8. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec 18; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

  • 9. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
    O'Sullivan S, Akveld M, Burke CM, Poulter LW.
    Am J Respir Crit Care Med; 2003 Mar 01; 167(5):745-50. PubMed ID: 12480610
    [Abstract] [Full Text] [Related]

  • 10. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W, McKay AJ, Tudur Smith C, Williamson PR, James M, Price D, MASCOT Study Group.
    Health Technol Assess; 2013 Feb 01; 17(4):1-218. PubMed ID: 23380178
    [Abstract] [Full Text] [Related]

  • 11. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun 01; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 12. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB, Rosario N, Aristizabal G, Loeys T, Noonan G, Gaile S, Smugar SS, Polos PG.
    Ann Allergy Asthma Immunol; 2010 Jun 01; 104(6):511-7. PubMed ID: 20568384
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug 01; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 14. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
    American Lung Association Asthma Clinical Research CentersWake Forest University, Winston-Salem, NC, USA., Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA.
    N Engl J Med; 2007 May 17; 356(20):2027-39. PubMed ID: 17507702
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
    Ostrom NK, Decotiis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza Rosenzweig JR, Crim C.
    J Pediatr; 2005 Aug 17; 147(2):213-20. PubMed ID: 16126052
    [Abstract] [Full Text] [Related]

  • 16. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
    J Allergy Clin Immunol; 2005 Feb 17; 115(2):233-42. PubMed ID: 15696076
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jun 17; 96(6):808-18. PubMed ID: 16802768
    [Abstract] [Full Text] [Related]

  • 18. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 17; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 19. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, Hustad CM, Edelman JM.
    Am J Med; 2005 Jun 17; 118(6):649-57. PubMed ID: 15922697
    [Abstract] [Full Text] [Related]

  • 20. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
    Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, Zhang J, Reiss TF.
    Am J Respir Crit Care Med; 1999 Dec 17; 160(6):1862-8. PubMed ID: 10588598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.